We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-0.13%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.9B
AUM Growth
+$27.7M
Cap. Flow
+$64.6M
Cap. Flow %
3.39%
Top 10 Hldgs %
15.8%
Holding
781
New
57
Increased
347
Reduced
285
Closed
71
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AFT
301
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$1.32M 0.07%
83,600
+29,140
+54% +$458K
XEL icon
302
Xcel Energy
XEL
$48.6B
$1.32M 0.07%
21,094
+1,355
+7% +$91.5K
RGNX icon
303
Regenxbio
RGNX
$704M
$1.29M 0.07%
30,888
+10,576
+52% +$381K
SRPT icon
304
Sarepta Therapeutics
SRPT
$1.89B
$1.29M 0.07%
13,988
+4,790
+52% +$369K
WMB icon
305
Williams Companies
WMB
$88.3B
$1.29M 0.07%
49,724
-9,696
-16% -$244K
XOM icon
306
ExxonMobil
XOM
$658B
$1.28M 0.07%
21,841
-10,965
-33% -$625K
T icon
307
AT&T
T
$168B
$1.28M 0.07%
62,961
-8,727
-12% -$183K
APD icon
308
Air Products & Chemicals
APD
$68.5B
$1.28M 0.07%
4,981
+3,851
+341% +$1.07M
HRL icon
309
Hormel Foods
HRL
$13.4B
$1.27M 0.07%
30,986
+941
+3% +$42.4K
PCRX icon
310
Pacira BioSciences
PCRX
$971M
$1.27M 0.07%
22,606
-3,640
-14% -$210K
EMN icon
311
Eastman Chemical
EMN
$8.54B
$1.24M 0.07%
12,313
+4,747
+63% +$524K
TEVA icon
312
Teva Pharmaceuticals
TEVA
$42.3B
$1.23M 0.06%
125,913
-5,435
-4% -$50.9K
MAIN icon
313
Main Street Capital
MAIN
$5.52B
$1.22M 0.06%
29,687
-14
-0% -$582
ECF
314
Ellsworth Growth & Income Fund
ECF
$173M
$1.22M 0.06%
91,168
+169
+0.2% +$2.45K
AES icon
315
AES
AES
$10.5B
$1.22M 0.06%
53,225
+20,629
+63% +$501K
PAGS icon
316
PagSeguro Digital
PAGS
$2.49B
$1.22M 0.06%
23,485
-477
-2% -$26.8K
EVR icon
317
Evercore
EVR
$11.6B
$1.21M 0.06%
9,011
+1,411
+19% +$192K
JPI
318
DELISTED
Nuveen Preferred Securities & Income Opportunities Fund
JPI
$1.19M 0.06%
47,844
-14,304
-23% -$367K
DPZ icon
319
Domino's
DPZ
$11.9B
$1.18M 0.06%
2,476
-265
-10% -$134K
UPBD icon
320
Upbound Group
UPBD
$1.11B
$1.18M 0.06%
20,952
+2,083
+11% +$123K
NKE icon
321
Nike
NKE
$61.3B
$1.18M 0.06%
8,104
-3,141
-28% -$512K
VISN
322
Vistance Networks Inc
VISN
$2.69B
$1.17M 0.06%
86,136
+3,302
+4% +$56.8K
NOK icon
323
Nokia
NOK
$52.8B
$1.16M 0.06%
213,363
+8,178
+4% +$47.5K
INO icon
324
Inovio Pharmaceuticals
INO
$80M
$1.15M 0.06%
13,402
+4,587
+52% +$460K
INTC icon
325
Intel
INTC
$490B
$1.14M 0.06%
21,378
-8,492
-28% -$460K

Similar funds

Hennion & Walsh Asset Management's Q3 2021 Portfolio in Review

As of Q3 2021, Hennion & Walsh Asset Management held 781 positions worth $1.9B, up 1.5% from $1.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hennion & Walsh Asset Management deployed $64.6M of net new capital in Q3 2021, opening 57 new positions and adding to 347 existing holdings. Its largest new stake was iShares International Equity Factor ETF: 328,462 shares worth $9.53M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $5.8M trimmed.

  • Hennion & Walsh Asset Management's largest Q3 2021 buy was iShares International Equity Factor ETF: 328,462 shares worth $9.53M.
  • Hennion & Walsh Asset Management added most to BlackRock MuniHoldings Fund in Q3 2021, an estimated $6.67M increase.
  • Hennion & Walsh Asset Management's biggest Q3 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $5.8M.
  • Hennion & Walsh Asset Management fully exited MFS High Income Municipal Trust in Q3 2021, selling an estimated $5.58M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 16% of its $1.9B portfolio in Q3 2021.
  • Hennion & Walsh Asset Management opened 57 new positions and closed 71 in Q3 2021.
  • Hennion & Walsh Asset Management's portfolio value rose 1.5% quarter-over-quarter to $1.9B.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.